Sublingual Immunotherapy for Japanese Cedar Pollinosis
Background: Although subcutaneous immunotherapy may cure allergic diseases, it is not commonly used in Japan because of the pain and risk of anaphylactic shock. Sublingual immunotherapy(SLIT)overcomes these limitations and although it is the most advanced form of local immunotherapy for clinical app...
Main Authors: | Minoru Gotoh, Kimihiro Okubo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2005-01-01
|
Series: | Allergology International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893015310200 |
Similar Items
-
Sublingual Immunotherapy for Japanese Cedar Pollinosis
by: Kimihiro Okubo, et al.
Published: (2009-01-01) -
An analysis of factors associated with compliance and dropout of sublingual immunotherapy on Japanese cedar pollinosis patients
by: Imanaka, Takahiro
Published: (2019) -
A Randomized Double-Blind Comparative Study of Sublingual Immunotherapy for Cedar Pollinosis
by: Kimihiro Okubo, et al.
Published: (2008-01-01) -
Delay of Onset of Symptoms of Japanese Cedar Pollinosis by Treatment with a Leukotriene Receptor Antagonist
by: Minoru Gotoh, et al.
Published: (2011-01-01) -
Association of Japanese cedar pollinosis and sensitization with HLA-DPB1 in the Japanese adolescent
by: Wataru Morii, et al.
Published: (2018-01-01)